Enzymatica publishes annual report for 2022
LUND, Sweden, April 5, 2023 /PRNewswire/ -- The annual report for Enzymatica 2022 was published today (in Swedish) on the company's website: https://www.enzymatica.com/sv/investerare/finansiella-rap...
Enzymatica AB (publ), a life science company, develops and sells products that treat and alleviate infections and symptoms in the upper respiratory tract. The company's product includes ColdZyme, a mouth spray to treat and alleviate cold and flu symptoms. It also provides enzyme formulations for skin care. The company offers its products through contract organizations and partner agreements with distributors who sell the products under the ViruProtect, STADAProtect, and Bisolviral brand names. Enzymatica AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
1.74 | |
1.81 | |
- | |
1.8 | |
1.96 | |
1.65-4.25 | |
437 M | |
243 M | |
44 248 K | |
-0.0386 | |
0.041 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
LUND, Sweden, April 5, 2023 /PRNewswire/ -- The annual report for Enzymatica 2022 was published today (in Swedish) on the company's website: https://www.enzymatica.com/sv/investerare/finansiella-rap...
LUND, Sweden, Feb. 17, 2023 /PRNewswire/ -- Significant events during the quarter Significant events after the quarter On October 31, the journal Respiratory Research published an in-vitro study fr...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: